A new era for Waldenstrom macroglobulinemia: MYD88 L265P
- PMID: 23723443
- DOI: 10.1182/blood-2013-04-494849
A new era for Waldenstrom macroglobulinemia: MYD88 L265P
Abstract
In this issue of Blood, Poulain et al demonstrate the high prevalence of the MYD88 L265P somatic mutation in patients with Waldenstrom macroglobulinemia (WM) and provide insight into its biological relevance in the growth and survival of WM.
Comment on
-
MYD88 L265P mutation in Waldenstrom macroglobulinemia.Blood. 2013 May 30;121(22):4504-11. doi: 10.1182/blood-2012-06-436329. Epub 2013 Mar 26. Blood. 2013. PMID: 23532735
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources